Latest filing published 18 Sept 2026 for Sionna Therapeutics, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Charlotte McKee in Sionna Therapeutics, Inc. In total, 2 filings cover trades dated 17 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 18 September 2026 came the latest disclosure, a share grant in Sionna Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations